Wei sheng yan jiu = Journal of hygiene research 2011-05-01

[Distribution and elimination of thiabendazole and its metabolite residue in laying hens].

Nan Shang, Juan Guo, Yin Zhang, Hao Wang, Jing Zhang, Qingshan Li, Bing Shao

Index: Wei Sheng Yan Jiu 40(3) , 365-7, 374, (2011)

Full Text: HTML

Abstract

To explore the distribution and elimination of thiabendazole and its metabolite 5-hydrothiabendazole residues in the hens tissues including liver, muscle, heart, fat, as well as in eggs.Laying hens were orally administred thiabendazole for 5 consecutive days (100mg per hen daily) and then the hens were sacrificed at the times of 1 day, 3 days, 5 days and 7 days after the end of treatment. Eggs, liver,muscle,fat and heart tissues were collected and homogenized. The samples were extracted by acetonitrile, further concentrated and purified by an Oasis MCX cartridge, and then the contents of thiabendazole and 5-hydrothiabendazole in tissue homogenates determinated by liquid chromatography electrospray ionisation tandem mass spectrometry (UPLC-ESI-MS/MS).The major residues in the tissue homogenates was 5-hydroxythiabendazole, with more higher concentrations than thiabendazole. Egg samples presented the large majority of both drug residues. For the tissue homogenates,the total concentrations of thiabendazole and 5-hydrothiabendazole residues followed the order of liver > heart > muscle > fat at 1 day after the treatment. The withdrawal period of thiabendazole for eggs was about 7 days.Distribution and elimination of thiabendazole and its metabolite residues in laying hens were primarily studied in this study.


Related Compounds

  • 5-hydroxy Thiabend...
  • Thiabendazole

Related Articles:

Multi-residue Determination of Polar Veterinary Drugs in Livestock and Fishery Products by Liquid Chromatography/Tandem Mass Spectrometry.

2015-01-01

[J. AOAC Int. 98(1) , 230-47, (2015)]

Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells.

2000-07-03

[Chem. Biol. Interact. 127(2) , 109-24, (2000)]

In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.

2009-06-01

[Drug Metab. Dispos. 37 , 1286-1294, (2009)]

Determination of thiabendazole, 5-hydroxythiabendazole, fenbendazole, and oxfendazole in milk.

1990-01-01

[J. Assoc. Off. Anal. Chem. 73(3) , 368-73, (1990)]

Thiabendazole and 5-hydroxythiabendazole in the plasma of sheep.

1985-12-01

[J. Vet. Pharmacol. Ther. 8(4) , 413-4, (1985)]

More Articles...